BVS vs CE · rev $573.3M vs rev $10.28B
Bioventus Inc (BVS) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BVS currently screens at market cap $495.1M. CE currently screens at market cap $5.92B.
Not investment advice. Open the BVS and CE stock pages for the full models.
Not investment advice.